2025 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer
Overview
NA
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Mark Pegram, MD
Date of Release
June 24th, 2025
Related Material
-1773064384760.webp&w=3840&q=75)
2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer
Breast
1 Chapter
Non-CME Credit Course
-1773063945796.webp&w=3840&q=75)
2026 Winter Cancer Symposium | New therapies for Metastatic Hormone Receptor Positive Breast Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs
Breast
1 Chapter
Non-CME Credit Course